Skip to main content
Caplight Logo









Synex Medical

Synex Medical

Private
TorontoHealthcare & Life Scienceshttps://synexmedical.com/

Last Round

Series A

Sep 22, 2024

Total Funding Raised

$27.05M

Company Overview

Synex Medical is a health technology company that develops non-invasive health monitoring technology using magnetic resonance spectroscopy to provide real-time measurements of blood metabolites like glucose and lactate.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Health IoT, Sensors

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

non-invasive glucose monitorcontinuous glucose monitorCGMwearable metabolic monitormagnetic resonance spectroscopybiomarker trackingneedle-free blood testinghealth wearablemetabolic healthpersonalized medicinediabetes managementbiohackinghealth IoTdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synex Medical Comparables

Compare Synex Medical with similar companies based on industry and business-model similarity.

Synex Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Liom Health AG
86%
Afon Technology
86%
Biolinq
84%

Synex Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 22, 2024
SeedOct 27, 2020

Key People

Founding team and executive leadership

Ben Nashman

Founder And Chief Executive Officer

Founding Team

Synex Medical Investors

Notable investors and investment history

Synex Medical investors
InvestorRounds
FundomoSeries A
Khosla VenturesSeries A
AccompliceSeries A, Seed
Radical VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 22, 2024

    $22M round with participation from Khosla Ventures and Accomplice.

  • Oct 27, 2020

    $5.25M round led by Accomplice.

Recent news

Latest coverage and updates

  • has_revenueSep 2, 2026

    Synex Medical had revenue of $11.3M on Sep 1st '25.

Synex Medical Filings

Explore SEC and related filing metadata, where available.

Synex Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Synex Medical's valuation, stock price, and market status.

Is Synex Medical a public or private company?

Synex Medical is a private company.

What is the current stock price of Synex Medical?

Synex Medical is a private company, so its shares have no public market price. Caplight tracks Synex Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Synex Medical worth (valuation)?

Valuation information for Synex Medical is not publicly available.

Can I buy Synex Medical stock?

Synex Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Synex Medical's last funding round?

Synex Medical's most recent funding round was Series A on September 22, 2024.

Who are the main investors in Synex Medical?

Key investors in Synex Medical include Accomplice.

Will Synex Medical IPO soon?

No public IPO plans have been announced for Synex Medical.

How can I track Synex Medical secondary market activity?

Caplight tracks bids, offers, and trades in Synex Medical's shares on secondary markets.

Firmographic Details

HeadquartersToronto
Employee Range31
Year Founded2017
Last FundingSep 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?